Showing results (11-20 of 247) with videos related to
Sort By:
Pageof 25
The Journal of Thoracic and Cardiovascular Surgery|April 1, 1995
Differential sensitivity of thoracic malignant tumors to adenovirus-mediated drug sensitization gene therapyW R Smythe, H C Hwang, A A Elshami, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 1993
Role of integrins and other cell adhesion molecules in tumor progression and metastasisS M AlbeldaEXS|January 1, 1992
Differential expression of integrin cell-substratum adhesion receptors on endotheliumS M AlbeldaAmerican Journal of Respiratory Cell and Molecular Biology|March 1, 1991
Endothelial and epithelial cell adhesion moleculesS M AlbeldaCancer Gene Therapy|July 27, 1999
The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancerN P Rizk, M Y Chang, C El Kouri, et al.The Annals of Thoracic Surgery|January 13, 2001
Efficacy of repeated adenoviral suicide gene therapy in a localized murine tumor modelE S Lambright, S D Force, M E Lanuti, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 6, 2000
Effect of preexisting anti-herpes immunity on the efficacy of herpes simplex viral therapy in a murine intraperitoneal tumor modelE S Lambright, E H Kang, S Force, et al.Gene Therapy|June 27, 2001
Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacyE S Lambright, K Amin, R Wiewrodt, et al.Virology|September 15, 1996
Herpes simplex 1716--an ICP 34.5 mutant--is severely replication restricted in human skin xenografts in vivoB P Randazzo, J C Kucharczuk, L A Litzky, et al.Cancer Gene Therapy|April 19, 2000
Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapyG Coukos, A Makrigiannakis, S Montas, et al.Pageof 25